IL-1β and IL-18 are key inflammatory mediators and their association with obesity and obesity-associated diseases, such as T2DM, atherosclerosis and NAFLD, is outlined below. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.